+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

The Global Digital Respiratory Solutions Market 2009-2023

  • ID: 4803972
  • Report
  • Region: Global
  • 122 Pages
  • Research2Guidance
1 of 5

FEATURED COMPANIES

  • Adherium
  • AsthmaMD
  • AstraZeneca
  • Cohero Health
  • Kaia Health Software GmbH
  • Novartis
  • MORE

The Global Digital Respiratory Solutions Market 2009-2023 report is the first attempt to provide a comprehensive quantitative and qualitative analysis of the global market for digital respiratory solutions. The study concentrates on sizing the global digital respiratory solutions market, analyzing the digital strategies of key players, discussing and evaluating trends, and providing a two-scenario outlook for the future market developments. It also provides guidance as to what is needed to create more value for patients and eventually establish daily use for digital respiratory solutions.

Asthma and COPD are one of the most dangerous global epidemics, which affect an increasingly large number of people in the world. Both diseases are responsible for a high economic burden in terms of disability, production loss, and premature mortality. Pharma, med-tech, and start-ups are now positioning themselves to be ready when the digital respiratory solutions market will take off. According to the World Health Organization (WHO), there were approximately 334M diagnosed asthma patients in the world in 2017, which amounted to 4.4% of the entire global population in the same year. At the same time, the estimated number of COPD-affected people amounted to 250M globally in 2017, constituting 3.3% of the global population.

The digital respiratory market is still at an emerging stage and the size of the opportunity is huge. Its key players such as Propeller Health, Adherium, Cohero Health, MIR, NuvoAir, AsthmaMD, Kaia Health Software, Tactio Health, AstraZeneca and Novartis are strengthening their positions in the digital respiratory solutions market to capture some of its enormous potential in the future. The new “Global Digital Respiratory Solutions Market 2009-2023” report pays special attention to analyzing top market players, their perceived strategies and digital respiratory offerings.

A digital respiratory solution can consist of a connected device (such as an inhaler and/or a spirometer), an app, and additional services and web portals for healthcare professionals (HCPs), patients and/or caregivers.

The global digital respiratory solutions market report provides a comprehensive quantitative and qualitative analysis of the digital respiratory market identifies major barriers that hinder the market’s development and suggests how to overcome them to get on the growth track. It covers the time frame between 2009 and 2018 to illustrate both the current status and the history of the market. Based on actual market sizes and future trends, the report also gives a five-year forecast for the period from 2019 to 2023.

The analysis highlights key market KPIs, including the following:

  • The size of the addressable market for digital respiratory solutions.
  • Various metrics that show the size and development of the demand and supply side of the market: the number of downloads, active users, apps, publishers.
  • The breakdown of current and future revenue streams from digital content, connected devices, services (including coaching), bundles, technology licensing, and advertising and promotion.

The questions the report answers:

  • What are the strategies of leading market players?
  • How many downloads and users are there now and will be in the future?
  • How big will the market be by 2023?
  • What are the current and future main revenue sources?
  • Which market entry strategies work best?
  • Which countries offer the biggest market potentials?

The report pays special attention to evaluating the trends that have shaped the industry over the last 2-3 years. It gives guidance as to what is needed to create more value for patients and eventually establish daily use for digital respiratory solutions. Finally, three principle market entry strategies are discussed and evaluated.

The analyst has been monitoring the digital health market since 2010. This report will act as a baseline for the future analysis of the digital respiratory solution market.



Please note that an Enterprise price will provide you with a 30 minute report consultation with a research analyst.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Adherium
  • AsthmaMD
  • AstraZeneca
  • Cohero Health
  • Kaia Health Software GmbH
  • Novartis
  • MORE

1 Scope of the report

2 Management summary

3. Global digital respiratory opportunity
3.1. Asthma and COPD: global prevalence and target group for digital solutions
3.2. Target groups for digital respiratory solutions: Top-10 countries

4. Current status of the market
4.1. Digital respiratory apps: structure and growth (2016-2018)
4.2. Connected devices and apps: classification and connectivity status
4.3. Download and usage trends in the respiratory app market (2016-2018)
4.4. Revenue trends and developments in the respiratory app market (2016-2018)
4.5. Clinical trials in the mobile respiratory market: focus on adherence solutions

5. The digital respiratory market ecosystem
5.1. Digital respiratory ecosystem: Key types of players
5.2. Digital respiratory publishers: Key characteristics
5.3. Competitive landscape of respiratory app publishers

6. Leading market players: Company profiles
6.1. Reciprocal Labs (Propeller Health)
6.2. Adherium
6.3. Cohero Health
6.4. Medical International Research (MIR)
6.5. NuvoAir
6.6. AsthmaMD
6.7. Kaia Health Software GmbH
6.8. Tactio Health
6.9. AstraZeneca
6.10. Novartis

7. Digital respiratory market trends: Ten major barriers and strategies to overcome them
7.1. Ten barriers to mass adoption of digital respiratory solutions
7.2. Market entry strategies for the digital respiratory market

8. Outlook: The next five years to 2023
8.1. The global addressable target group size and active user forecast (2017-2022)
8.2. Market development scenarios: baseline and accelerated uptake
8.3. Downloads and usage of respiratory solutions (2018-2023)
8.4. Revenue from respiratory solutions by source (2017-2023)

9. Appendix
9.1. Respiratory apps market status per country in 2018
9.1.1. Germany
9.1.2. The United States
9.1.3. The United Kingdom
9.1.4. France
9.1.5. Australia
9.1.6. Canada
9.1.7. Malaysia
9.1.8. Switzerland
9.1.9. India
9.1.10. Austria
9.2. Digital respiratory solutions: Addressable target group and market size in 30 countries
9.3. About the Authors

LIST OF FIGURES
Figure 1: Global target group size for digital respiratory solutions (2017): asthma vs. COPD
Figure 2: Top-ten largest country-specific addressable target groups – asthma (2017)
Figure 3: Top-ten largest country-specific addressable target groups – COPD (2017), COPD
Figure 4: Global number of digital respiratory apps (2009-2018 Sept)
Figure 5: Number of digital respiratory apps in four global regions (2017 – 2018, Sept)
Figure 6: Global number of digital respiratory apps by platform (2009-2018 Sept)
Figure 7: Number of respiratory apps by type of disease globally, % of the total number of apps (2009 – Sept 2018)
Figure 8: Breakdown of respiratory apps by type of disease globally, % of the total number of apps (2017 and Sept 2018)
Figure 9: Breakdown of respiratory apps by use case category globally, % of the total number of apps (2017 and Sept 2018)
Figure 10: Number of connected respiratory apps globally, % of the total number of apps (2010 – Sept 2018)
Figure 11: Breakdown of connected respiratory apps by type of device globally, % of the total number of apps (2017 and 2018, 8 months)
Figure 12: Global number of downloads and monthly active users of mobile respiratory apps, (2016 – 2018E)
Figure 13: Breakdown of respiratory apps by type of disease globally, % of the total number of downloads (2017 and 2018, 8 months)
Figure 14: Breakdown of respiratory apps by type of disease globally, % of the total number of monthly active users (2017 and 2018, 8 months)
Figure 15: Breakdown of respiratory apps by use case globally, % of the total number of downloads (2017 and 2018, 8 months)
Figure 16: Breakdown of respiratory apps by use case globally, % of the total number of monthly active users (2017 and 2018, 8 months)
Figure 17: Breakdown of respiratory app downloads and monthly active users by regions, % of the total (2018, 8 months)
Figure 18: Global number of respiratory app downloads by platform (2016-2018E)
Figure 19: Global number of respiratory apps monthly active users by platform (2016-2018E)
Figure 20: IAP apps and paid download apps as % of the global number of digital respiratory apps (2009- 2018 Sept)
Figure 21: IAP apps and paid download apps as % of global respiratory app downloads (2016-2018E)
Figure 22: Breakdown of respiratory app downloads and monthly active users by type of device, % of the total (2018, 8 months)
Figure 23: Breakdown of respiratory apps by the number of downloads globally, % of the total number of apps (Sept 2017 and Sept 2018)
Figure 24: Breakdown of respiratory apps by the year of the last update, % of the total number of apps (Sept 2018)
Figure 25: Global digital respiratory market revenue 2016- 2018E (US$ million)
Figure 26: Global digital respiratory market revenue by major source, 2017 vs 2018E (% of total revenue)
Figure 27: Global digital respiratory market revenue by region, 2018E
Figure 28: Digital respiratory ecosystem: supply-side
Figure 29: Global number of respiratory app publishers by platform (2009 – Sept 2018)
Figure 30: Global number of respiratory app publishers by type of disease (2008 – Sept 2018)
Figure 31: Breakdown of respiratory apps publishers by the app portfolio size, % of the total number of unique publishers (Sept 2018)
Figure 32: Breakdown of respiratory apps publishers by the type of company/institution, % of the total number of unique publishers (Sept 2018)
Figure 33: Top-10 publishers’ market shares, % of total diabetes app downloads (2017-2018, preliminary results)
Figure 34: Comparison of the digital respiratory app market with other digital health market segments (downloads, usage in 2017)
Figure 35: Service expansion for the services play market entry strategy
Figure 36: The global target group for digital respiratory solutions (2017 – 2023)
Figure 37: The global number of digital respiratory app downloads (2017-2023)
Figure 38: The global number of monthly active users (MAUs) of digital respiratory apps (2017-2023)
Figure 39: The global number of connected monthly active users (MAUs) of digital respiratory apps (2017-2023)
Figure 40: Global digital respiratory market revenue: baseline scenario and accelerated uptake scenario (2017-2023)
Figure 41: Global digital respiratory market revenue by source: baseline scenario (2017-2023)
Figure 42: Global digital respiratory market revenue by source: accelerated uptake scenario (2017-2023)

LIST OF TABLES
Table 1: Types of connected inhalers
Table 2: Examples of wireless mobile-connected handheld spirometers
Table 3: Propeller Health’s digital respiratory ecosystem
Table 4: Propeller Health’s app portfolio performance
Table 5: Adherium’s digital respiratory ecosystem
Table 6: Adherium’s app portfolio performance
Table 7: Cohero Health’s digital respiratory ecosystem
Table 8: Cohero Health’s app portfolio performance
Table 9: MIR’s mobile respiratory ecosystem
Table 10: MIR’s app portfolio performance
Table 11: Nuvo Air’s digital respiratory ecosystem
Table 12: NuvoAir’s app portfolio performance
Table 13: Asthma MD’s digital respiratory ecosystem
Table 14: Asthma MD’s app portfolio performance
Table 15: Kaia’s digital respiratory ecosystem
Table 16: Kaia’s app portfolio performance
Table 17: Tactio Health’s digital respiratory ecosystem
Table 18: Tactio Health’s app portfolio performance
Table 19: AstraZeneca’s digital respiratory ecosystem
Table 20: AstraZeneca’s app portfolio performance
Table 21: Novartis’ digital respiratory ecosystem
Table 22: Novartis’ app portfolio performance
Table 23: Germany´s respiratory app market (2017-2018, 8 months)
Table 24: The US´s respiratory app market (2017-2018, 8 months)
Table 25: The UK´s respiratory app market (2017-2018, 8 months)
Table 26: France´s respiratory app market (2017-2018, 8 months)
Table 27: Australia´s respiratory app market (2017-2018, 8 months)
Table 28: Canada´s respiratory app market (2017-2018, 8 months)
Table 29: Malaysia´s respiratory app market (2017-2018, 8 months)
Table 30: Switzerland´s respiratory app market (2017-2018, 8 months)
Table 31: India´s respiratory app market (2017-2018, 8 months)
Table 32: Austria´s respiratory app market (2017-2018, 8 months)
Table 33: Asthma and COPD: Top-30 country markets by addressable target groups (2018)

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Adherium
  • AsthmaMD
  • AstraZeneca
  • Cohero Health
  • Kaia Health Software GmbH
  • Novartis
  • MORE

This report is a comprehensive factbook about digital solutions that address patients affected by chronic lung diseases (such as asthma and COPD) and their caregivers. It analyses in detail the current status of the market, looks at current trends and discusses how it will evolve in the next five years. Major attention is paid to demonstrating service offerings and strategies of key players.

Digital respiratory solutions comprise of connected devices (e.g. inhalers or spirometers), mobile applications, additional services (e.g. coaching or training), and HCP/caregivers portals.
 
This report evaluates possible market entry options based on a profound market deep dive, assessment of competitor strategies, and insights from other digital health market segments, such as diabetes and weight loss.

The size of the opportunity is enormous and potentially even bigger than the digital diabetes care market.
 
The Addressable Target Group is Enormous and Set to Grow
Out of 500M asthma & COPD patients worldwide, 210M can be targeted with digital respiratory solutions already today.
 
The Market is 3-5 Years Behind Other Digital Health Markets, Such as Diabetes, Weight Loss or Fitness
• There are 400+ digital respiratory solutions available worldwide.
• Usage of digital is still low: Solutions reach to <1% of the addressable target group.
• Current business models of digital respiratory solutions focus on connected device sales, mostly inhaler sensors and spirometers.

No company has yet gained a dominant market position. Market shares still vary significantly from year to year. There is still room to enter!

Note: Product cover images may vary from those shown
5 of 5
  • Adherium
  • AsthmaMD
  • AstraZeneca
  • Cohero Health
  • Kaia Health Software GmbH
  • Medical International Research (MIR)
  • Novartis
  • NuvoAir
  • Reciprocal Labs (Propeller Health)
  • Tactio Health
Note: Product cover images may vary from those shown
Adroll
adroll